| | | |

The Importance of Subtype in PET Scanning for Mesothelioma Prognosis

PET scanning for mesothelioma prognosis

A new study of PET scanning for mesothelioma prognosis shows how much radioactive tracer a tumor absorbs can predict survival. This is especially true in people with the epithelioid mesothelioma subtype. 

The study comes from the Sungkyunkwan University School of Medicine in Seoul, South Korea. Researchers studied the medical records of dozens of mesothelioma patients diagnosed between 2009 and 2018.

They found that SUVmax, a key factor in PET scanning for mesothelioma, is directly related to mesothelioma survival. 

How PET Scanning Works

Mesothelioma diagnosis is challenging. Pleural mesothelioma grows quickly on the membrane around the lungs. It is one of the rarest and deadliest cancers. Positron emission tomography (PET) combined with computed tomography (CT) can help with diagnosis. 

During a PET scan, the patient gets an injection of a radioactive tracer called FDG.  Cancer cells absorb or “uptake” more of the tracer than normal cells. How much they absorb is the standard uptake value (SUV). 

The imaging scan shows the percentage of cells that absorb the maximum amount of tracer. This number is the SUVmax. Together with a CT image, SUVmax can provide vital information about a mesothelioma tumor

PET Scanning for Mesothelioma Prognosis

Doctors can also use PET scanning for mesothelioma prognosis. Prognosis is not just about predicting survival. A prognostic test like a PET scan can show if a mesothelioma treatment is working. 

Prognostic tools are especially important with fast-growing cancers like mesothelioma. If one mesothelioma treatment does not work, doctors must pivot quickly to try another one. 

The new Korean study shows how variable SUVmax can be in PET scanning for mesothelioma prognosis. Mesothelioma subtype appears to make the difference. 

Subtypes Make the Difference

Researchers looked at the records of 54 pleural mesothelioma patients. Thirty-four of the patients had the epithelioid mesothelioma subtype. Thirteen had biphasic or sarcomatoid mesothelioma. The remaining seven were unclassified.

The SUVmax values were much higher in people with non-epithelioid mesothelioma. But it did not appear to relate to how long they lived. 

“In multivariate analysis, SUVmax was significantly associated with overall survival…but not in those with non-epithelioid subtype,” writes study author Jun Hyeok Lim. The SUVmax number only related to survival in the people with epithelioid mesothelioma.

Dr. Lim and colleagues conclude that SUVmax “is an independent prognostic factor” in PET scanning for mesothelioma prognosis. But they say doctors should also consider a patient’s subtype when deciphering the SUVmax number. 

Epithelioid mesothelioma is by far the most common subtype. It is also the subtype that is most responsive to treatment. 

Source:

Lim, JH, et al, “Prognostic value of SUVmax on 18F-fluorodeoxyglucose PET/CT scan in patients with malignant pleural mesothelioma”, February 18, 2020, PLoS One, https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0229299

Similar Posts

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • | | |

    Mesothelioma Nurses Ready for New Cases in Australia

    Australia is bracing for an expected new wave of mesothelioma cases in the next decade and the Lung Foundation of Australia is taking action now to get ready. The Foundation has paid for ten nurses from around the country to receive specialized training in helping patients and families cope with mesothelioma. The nurses, who have recently completed the training, are now equipped to lead treatment planning for these complex cancer patients and to help other nurses do the same. Pleural mesothelioma is an aggressive cancer that occurs in the lining around the lungs. It is caused by exposure to asbestos dust, a toxin that was once alarmingly prevalent in Australia where it was mined and heavily used in construction. Because…

  • |

    Mesothelioma Blood Test May Be Possible

    An international team of researchers is studying the proteins found on the surface of cancer cells in an effort to improve mesothelioma diagnosis. The team, made up of scientists from the US, Switzerland, Italy and Chile, has just published their findings on a new kind of test to identify protein-derived mesothelioma biomarkers in blood serum. Mesothelioma is an aggressive cancer of the membranes around organs. Because the most common mesothelioma biomarker, mesothelin, is also overproduced by other kinds of cancer cells, it has only limited diagnostic value. A test to identify a set of proteins produced specifically by mesothelioma cells could greatly improve diagnostic accuracy. Led by Ferdinando Cerciello and Bernd Wollscheid of the Institute of Molecular Systems Biology in…

  • | |

    Spanish Mesothelioma Deaths Likely to Continue for Decades

    New research in Spain suggests that mesothelioma deaths will continue in the country until the “last surviving member” of the group of people exposed to occupational asbestos succumbs to the disease. Like many countries, Spain used asbestos heavily in the first half of the 20th century, especially in construction, where the mineral was prized for its durability, low cost, and resistance to fire and corrosion.  Asbestos was banned in Spain in 2002. Observing that more than 2.5 million metric tons of asbestos were imported into Spain from 1906 to 2002, researchers say deaths from mesothelioma have risen steadily. Between 1976 and 1980, a total of 491 Spanish people died of mesothelioma. By the 5-year period from 2006 to 2010, that…

  • | |

    Needle Biopsy “Simple, Safe & Accurate” for Mesothelioma

    Mesothelioma researchers in China say a biopsy method that involves a single skin puncture can produce good diagnostic results for mesothelioma patients with little pain or risk. The study focused on percutaneous (through the skin) biopsy in patients who had unexplained fluid buildup or swelling in their abdomens. Abdominal distension and fluid buildup (called ascites) can be signs of peritoneal mesothelioma, a rare but aggressive cancer of the abdominal lining caused by exposure to asbestos. Peritoneal mesothelioma accounts for less than 30% of all mesothelioma cases. Because the symptoms may be vague and often develop many decades after asbestos exposure, peritoneal mesothelioma can be especially challenging to diagnose.  Misdiagnosis and under-diagnosis are not uncommon. In the newest study on percutaneous…